PUNE, India, April 9, 2018 /PRNewswire/ --
According to a new market research report "Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 25.12 Billion by 2022 from USD 20.67 Billion in 2017, at a CAGR of 4.0% during the forecast period.
Browse 170 market data Tables and 31 Figures spread through 180 Pages and in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management Devices Market"
Early buyers will receive 10% customization on this report
Factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices are expected to propel the growth of the market. However, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the CM & CRM devices market.
The hospitals segment accounted for the largest share of the Cardiac Monitoring and Cardiac Rhythm Management Devices Market in 2017
By end user, the Cardiac Monitoring and Cardiac Rhythm Management Devices Market is classified into hospitals, home & ambulatory care settings, and other end users. In 2017, the hospitals segment accounted for the largest share of the market. The large share of this segment can primarily be attributed to the increasing use of these devices in hospitals, increasing burden of cardiovascular & coronary heart diseases, growing number of patient visits to physician offices for the principal diagnosis of CVD & CHD, and growing number of cardiac implant procedures.
The external defibrillators segment is expected to grow at the highest CAGR in defibrillators market during the forecast period
By type, the defibrillators market is divided into implantable and external defibrillators. The external defibrillators segment is expected to grow at the highest CAGR during the forecast period. This positive growth is attributed to the implementation of defibrillation programs in various countries and the launch of technologically advanced AED devices in the market
Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=55
Asia is expected to grow at the highest CAGR during the forecast period
On the basis of region, the CM & CRM devices market is segmented into North America, Europe, Asia, and RoW. Asia is expected to grow at the highest CAGR during the forecast period. Factors such as growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less stringent regulations are fueling the demand for CM & CRM devices in this region.
The Cardiac Monitoring and Cardiac Rhythm Management Devices Market is dominated by players such as Medtronic (Ireland), Abbott (US), Boston Scientific (US), BIOTRONIK (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands)
Know more about the Cardiac Monitoring and Cardiac Rhythm Management Devices Market:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062
Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets